Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    New Brunswick ; Camden ; New Jersey ; London : Rutgers University Press
    UID:
    b3kat_BV047683362
    Format: 1 online resource
    ISBN: 9780813575230 , 9780813563893
    Series Statement: Critical issues in health and medicine
    Note: Includes bibliographical references and index. - Description based on print version record and CIP data provided by publisher; resource not viewed
    Additional Edition: Erscheint auch als Druck-Ausgabe, Hardcover Connolly, Cynthia A. (Cynthia Anne), author Children and drug safety New Brunswick, New Jersey : Rutgers University Press, [2018] ISBN 9780813563886
    Additional Edition: Erscheint auch als Druck-Ausgabe, Paperback Connolly, Cynthia A. (Cynthia Anne), author Children and drug safety New Brunswick, New Jersey : Rutgers University Press, [2018] ISBN 9780813563879
    Language: English
    URL: Volltext  (kostenfrei)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    [Erscheinungsort nicht ermittelbar] : Rutgers University Press
    UID:
    gbv_1832240312
    Format: 1 Online-Ressource (260 p.)
    ISBN: 9780813563893
    Content: Winner of the 2018 Arthur J. Viseltear Award from the Medical Care Section of the American Public Health Association​ Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable. Open access edition funded by the National Endowment for the Humanities. The text of this book is licensed under a Creative Commons Attribution NonCommercial-NoDerivatives 4.0 International License: https://creativecommons.org/licenses/by-nc-nd/4.0
    Note: English
    Language: Undetermined
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    New Brunswick, Camden : Rutgers University Press
    UID:
    gbv_1678155357
    Format: 1 Online-Ressource (x, 250 Seiten) , Illustrationen
    ISBN: 9780813563893 , 9780813575230
    Series Statement: Critical issues in health and medicine
    Content: Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance—many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children’s risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable
    Content: Frontmatter -- Contents -- 1. Drug Therapy: From “Baby Killers” to Baby Savers, 1906–1933 -- 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933–1945 -- 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945–1961 -- 4. The Growth and Development of the Therapeutic Orphan, 1961–1979 -- 5. A “Big Business Built for Little Customers”: Candy Aspirin, Children, and Poisoning, 1947–1976 -- 6. Children and Psychopharmacology in Postwar America -- 7. Pediatric Drug Development and Policy after 1979 -- Appendix -- Acknowledgments -- Notes -- Index -- About the Author
    Note: Mode of access: Internet via World Wide Web.
    Additional Edition: ISBN 9780813563886
    Additional Edition: ISBN 9780813563879
    Additional Edition: Erscheint auch als Druck-Ausgabe Connolly, Cynthia A. Children and drug safety New Brunswick : Rutgers University Press, 2018 ISBN 9780813563886
    Additional Edition: ISBN 0813563887
    Additional Edition: ISBN 9780813563879
    Additional Edition: ISBN 0813563879
    Language: English
    Keywords: USA ; Kinderheilkunde ; Pharmakologie ; Geschichte 1906-1999
    URL: Cover
    URL: Cover
    URL: Cover
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    gbv_886365937
    Format: vii, 246 Seiten , Illustrationen , 23 cm
    ISBN: 9780813563886 , 0813563887 , 9780813563879 , 0813563879
    Series Statement: Critical issues in health and medicine
    Content: Drug therapy : from "baby killers" to baby savers, 1906-1933 -- New drugs, old problems in pediatrics : from therapeutic nihilism to the antibiotic era, 1933-1945 -- The child as drug development problem and business opportunity in a new era, 1945-1961 -- The growth and development of the therapeutic orphan : 1961-1979 -- A "big business built for little customers:" candy aspirin, children, and poisoning, 1947-1976 -- Children and psychopharmacology in postwar America -- Pediatric drug development and policy after 1979
    Note: Includes bibliographical references (pages 171-232) and index
    Additional Edition: ISBN 9780813563893
    Additional Edition: ISBN 9780813575230
    Additional Edition: ISBN 9780813575230
    Additional Edition: Erscheint auch als Online-Ausgabe Connolly, Cynthia A. (Cynthia Anne), author Children and drug safety New Brunswick, New Jersey : Rutgers University Press, [2018]
    Additional Edition: Erscheint auch als Online-Ausgabe Connolly, Cynthia A. Children and drug safety New Brunswick, Camden : Rutgers University Press, 2018 ISBN 9780813563893
    Additional Edition: ISBN 9780813575230
    Language: English
    Keywords: USA ; Kinderheilkunde ; Pharmakologie ; Geschichte 1906-1999
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    New Brunswick, NJ :Rutgers University Press,
    UID:
    edocfu_9959127902902883
    Format: 1 online resource : , 8
    ISBN: 9780813563893
    Series Statement: Critical Issues in Health and Medicine
    Content: Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance—many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children’s risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.
    Note: Frontmatter -- , Contents -- , 1. Drug Therapy: From “Baby Killers” to Baby Savers, 1906–1933 -- , 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933–1945 -- , 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945–1961 -- , 4. The Growth and Development of the Therapeutic Orphan, 1961–1979 -- , 5. A “Big Business Built for Little Customers”: Candy Aspirin, Children, and Poisoning, 1947–1976 -- , 6. Children and Psychopharmacology in Postwar America -- , 7. Pediatric Drug Development and Policy after 1979 -- , Appendix -- , Acknowledgments -- , Notes -- , Index -- , About the Author , In English.
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Rutgers University Press | New Brunswick, NJ :Rutgers University Press,
    UID:
    edocfu_9959276591702883
    Format: 1 online resource (p. )
    Edition: 1st ed.
    ISBN: 0-8135-6389-5
    Series Statement: Critical Issues in Health and Medicine
    Content: Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.
    Note: Frontmatter -- , Contents -- , 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- , 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- , 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- , 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- , 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- , 6. Children and Psychopharmacology in Postwar America -- , 7. Pediatric Drug Development and Policy after 1979 -- , Appendix -- , Acknowledgments -- , Notes -- , Index -- , About the Author , In English.
    Additional Edition: ISBN 0-8135-6388-7
    Language: English
    Keywords: Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Rutgers University Press | New Brunswick, NJ :Rutgers University Press,
    UID:
    almahu_9949225913302882
    Format: 1 online resource (p. )
    Edition: 1st ed.
    ISBN: 0-8135-6389-5
    Series Statement: Critical Issues in Health and Medicine
    Content: Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.
    Note: Frontmatter -- , Contents -- , 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- , 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- , 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- , 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- , 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- , 6. Children and Psychopharmacology in Postwar America -- , 7. Pediatric Drug Development and Policy after 1979 -- , Appendix -- , Acknowledgments -- , Notes -- , Index -- , About the Author , In English.
    Additional Edition: ISBN 0-8135-6388-7
    Language: English
    Keywords: Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Rutgers University Press | New Brunswick, NJ :Rutgers University Press,
    UID:
    edoccha_9959276591702883
    Format: 1 online resource (p. )
    Edition: 1st ed.
    ISBN: 0-8135-6389-5
    Series Statement: Critical Issues in Health and Medicine
    Content: Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.
    Note: Frontmatter -- , Contents -- , 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- , 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- , 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- , 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- , 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- , 6. Children and Psychopharmacology in Postwar America -- , 7. Pediatric Drug Development and Policy after 1979 -- , Appendix -- , Acknowledgments -- , Notes -- , Index -- , About the Author , In English.
    Additional Edition: ISBN 0-8135-6388-7
    Language: English
    Keywords: Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Did you mean 9780813562896?
Did you mean 9780810353893?
Did you mean 9780813543833?
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages